Coreline Soft, a pioneer in medical artificial intelligence (AI) imaging, is set to revolutionize the landscape of healthcare in Europe with its cutting-edge AI medical imaging solutions. The company will unveil its AVIEW product line at the European Congress of Radiology (ECR) 2024, the largest radiology conference in Europe, which attracts global experts and industry professionals.
With overseas sales approval and CE certification, Coreline Soft is ready to showcase its AVIEW products, including AVIEW LCS Plus for simultaneous diagnosis of chest diseases, AVIEW COPD for automatic analysis of chronic obstructive pulmonary disease, and AVIEW RT ACS, an AI-based fully automated contouring solution. This comprehensive range of products covers screening, diagnosis, treatment, and management in the medical field.
One of the key highlights of the exhibition will be the AVIEW LCS Plus, capable of screening three major pulmonary conditions in CT scans. Coreline Soft will present real-world applications of this technology in hospitals worldwide, emphasizing the benefits for medical professionals, workflow improvements, and enhanced diagnostic efficiency.
Coreline Soft has been actively expanding its presence in Europe, securing projects such as the multinational lung cancer screening initiative (iDNA) involving five European countries. The company’s competitiveness in the global lung cancer screening market is showcased through projects like the HANSE lung cancer screening in Germany and the ILSP lung cancer screening in Italy, led by the prestigious National Cancer Institute in Milan with 18 participating hospitals and cancer centers.
Furthermore, Coreline Soft has recently signed supply agreements with renowned institutions like Heidelberg University Hospital in Germany, Catania University Hospital in Italy, and the large imaging center group ImaGen in France. This positions the company to further extend its footprint in the European healthcare market.
Jason Seo, Director of Overseas Business Development at Coreline Soft, expressed the company’s commitment to the European market, stating, “We have accumulated expertise in entering local hospitals and national-level projects, positioning the European market as a forward base for the global market.” Coreline Soft’s goal is to strengthen its global presence and offer innovative AI solutions that advance healthcare practices not only in Europe but also beyond.
Harnessing the power of AI imaging, Coreline Soft is poised to revolutionize medical diagnosis and treatment with its AVIEW product line. By leveraging AI technology, this company aims to enhance the quality and efficiency of medical practices, ultimately improving patient outcomes. As technological advancements continue to reshape the healthcare industry, Coreline Soft stands at the forefront, leading the way towards a more advanced and effective healthcare system.
Use the share button below if you liked it.